Basel, Switzerland

Eva Rossmann

This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eva Rossmann: Innovator in Therapeutic Methods

Introduction

Eva Rossmann is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of therapeutic methods, particularly in the treatment of diseases and the reduction of adverse effects associated with therapeutic agents. Her innovative approach has garnered attention in the medical community.

Latest Patents

Eva Rossmann holds a patent related to a treatment method. The present invention pertains to methods of treating a disease and reducing the formation of anti-drug antibodies (ADAs) in response to the administration of a therapeutic agent. Furthermore, the invention addresses methods for treating B-cell proliferative disorders and minimizing adverse effects from T-cell activating therapeutic agents. This patent highlights her commitment to advancing medical treatments.

Career Highlights

Throughout her career, Eva has worked with notable companies, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas in therapeutic methods.

Collaborations

Eva has collaborated with esteemed colleagues, including Marina Bacac and Stefan Evers. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Eva Rossmann is a trailblazer in the field of therapeutic methods, with a focus on improving treatment outcomes for patients. Her patent and collaborations reflect her dedication to innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…